Skip to main content
S

Sandoz

Sandoz develops and supplies generic and biosimilar medicines across more than 100 countries, offering about 1,300 products including over 50 antibiotics.

Sandoz is a pharmaceutical company specialising in generic and biosimilar medicines. It develops and supplies high-quality, affordable versions of off-patent medicines, spanning cardiovascular, metabolism, oncology, immunology and anti-infective therapeutic areas. The company offers approximately 1,300 products and serves over 100 countries, drawing on more than 135 years of company history.

Its portfolio has two main pillars. Generic medicines cover a broad range of therapeutic areas, while biosimilar medicines provide versions of off-patent biologic drugs. Sandoz also supplies more than 50 antibiotics worldwide, including many that appear on the WHO Essential Medicines List.

Sandoz has been an independent, publicly traded company since October 2023, following its spin-off from Novartis. Its stated purpose centres on expanding access to medicines for patients globally, with an emphasis on affordability, sustainability and innovative solutions in pharmaceutical manufacturing and anti-infectives, oncology and immunology research.

Open jobs

No open jobs right now.